Co-Diagnostics (NASDAQ: CODX) announced that its Indian joint venture, CoSara Diagnostics Pvt. Ltd., has signed an agreement to expand its commercial and distribution territory across South Asia to include Bangladesh, Pakistan, Nepal and Sri Lanka, significantly increasing its addressable market to an estimated $13.0 billion. The expansion supports planned commercialization of the CoSara PCR Pro(R) point-of-care platform and SARAGENE(R) product line, subject to regulatory […]

A flurry of financings, strategic pivots, and technology-driven initiatives is energizing the small-cap space, as companies tap capital markets to chase growth across AI, biotech, and next-generation transportation. $TGNT, $AZTR, $WNW, $UCAR, $JDZG

Las Vegas, Nevada, March 20th, 2026, FinanceWire

CODX (NASDAQ:CODX) is making a strategic push to scale its global diagnostics platform, announcing a major expansion of its commercial and distribution footprint across South Asia through its joint venture, CoSara Diagnostics.